Phase I clinical and pharmacology study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempt at dose intensification using recombinant granulocyte colony-stimulating factor (Q33489257)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I clinical and pharmacology study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempt at dose intensification using recombinant granulocyte colony-stimulating factor |
scientific article |
Statements
1 reference
Phase I clinical and pharmacology study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempt at dose intensification using recombinant granulocyte colony-stimulating factor (English)
1 reference
Saltz L
1 reference
Sirott M
1 reference
Young C
1 reference
Tong W
1 reference
Niedzwiecki D
1 reference
Tzy-Jyun Y
1 reference
Tao Y
1 reference
Trochanowski B
1 reference
Wright P
1 reference
Barbosa K
1 reference
1 September 1993
1 reference
1 reference
1499-1507
1 reference
Identifiers
1 reference
1 reference